Stay tuned
GSK licenses Alteogen enzyme in bid to develop subQ Jemperli
GSK, through its oncology subsidiary Tesaro, is handing over $20 mill
Takeda's neuroscience field force hit with layoffs as key patent loss looms for Trintellix
Takeda is executing another round of layoffs, cutting 243 roles in th
Venner Shipley announces opening of new Bristol office
The firm already has a number of offices across the UK and Europe
AAX Biotech and Vascurie announce new neuro-oncology collaboration
The collaboration will help to advance a pipeline of antibody candida
Roche scales Genentech’s North Carolina site to $2B in major obesity market play
Roche is more than doubling its total commitment to a future facility
Stay tuned
© 1994 - 2026 B.M. Pharmaceuticals